Cigna Group (CI)
NYSE: CI
· Real-Time Price · USD
305.37
1.34 (0.44%)
At close: Sep 05, 2025, 3:59 PM
307.50
0.70%
After-hours: Sep 05, 2025, 07:58 PM EDT
Cigna Revenue Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 |
|---|---|---|---|---|---|
| Cigna Healthcare Revenue | 10.8B | 13.17B | 20.99B | 13.34B | 13.2B |
| Cigna Healthcare Revenue Growth | -18.00% | -37.27% | +57.36% | +1.09% | n/a |
| Evernorth Revenue | 57.83B | 52B | 95.99B | 52.64B | 49.55B |
| Evernorth Revenue Growth | +11.20% | -45.83% | +82.37% | +6.23% | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 3.43B | 3.8B | 3.74B | 3.52B | 3.63B | 3.67B | 3.75B | 3.58B | 3.44B | 3.55B | 3.48B | 3.14B | 3.25B | 3.24B | 3.41B | 3.1B | 3B | 3.3B | 3.79B | 3.31B | 3.29B | 3.26B | 3.62B | 3.35B | 3.16B | 3.19B | 2.78B | 2.87B | 2.7B | 2.68B | 9.96B | n/a | n/a | n/a | 82M | n/a | n/a | n/a | 92M | n/a | n/a | n/a |
| Selling, General, and Administrative Revenue Growth | -9.63% | +1.50% | +6.27% | -2.92% | -1.09% | -2.19% | +4.60% | +4.25% | -3.13% | +2.13% | +10.56% | -3.29% | +0.37% | -4.96% | +9.90% | +3.37% | -9.09% | -13.02% | +14.69% | +0.39% | +0.98% | -9.81% | +8.16% | +5.85% | -1.00% | +14.74% | -3.10% | +6.18% | +0.78% | -73.05% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |